Biopharma Sentiment Index | Q2 2026
Summary:
Understanding the macro-health of the drug development and biotech industry with EndPoints News Biopharma Sentiment Index. The latest BPSI shows significant improvements in biopharma conditions but raises questions about what comes next.
NSF puts new research grants to top universities on hold
Summary:
The US National Science Foundation (NSF) — a major funder of basic research — has restricted the flow of new research grants to a group of elite universities, including Duke University, Harvard University, Yale University and Princeton University
‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer
Summary:
Highly anticipated data presented at ASCO confirmed what’s been heralded as a medical breakthrough against a historically tough-to-treat tumor.
Innovent Biologics & Pfizer strike $10.5 bln cancer drug deal amid China biotech boom
Summary:
China’s Innovent Biologics and U.S. pharma giant Pfizer have agreed to a global licensing and collaboration deal worth up to $10.5 billion to develop 12 early-stage cancer medicines.
